<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nid</journal-id><journal-title-group><journal-title xml:lang="ru">Нефрология и диализ</journal-title><trans-title-group xml:lang="en"><trans-title>Nephrology and Dialysis</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1680-4422</issn><issn pub-type="epub">2618-9801</issn><publisher><publisher-name>Российское диализное общество</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">nid-593</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>НАБЛЮДЕНИЯ ИЗ ПРАКТИКИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CASE REPORTS</subject></subj-group></article-categories><title-group><article-title>Синдром Сагликера (Клиническое наблюдение)</article-title><trans-title-group xml:lang="en"><trans-title>Sagliker Syndrome (A clinical observation)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ветчинникова</surname><given-names>О. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Vetchinnikova</surname><given-names>O. N.</given-names></name></name-alternatives><email xlink:type="simple">olg-vetchinnikova@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кулибаба</surname><given-names>С. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kulibaba</surname><given-names>S. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Денисова</surname><given-names>Л. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Denisova</surname><given-names>L. B.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зулькарнаев</surname><given-names>А. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Zulkarnaev</surname><given-names>A. B.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Патюков</surname><given-names>К. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Patyukov</surname><given-names>K. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ГБУЗ МО «Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>M.F. Vladimirsky Moscow Regional Clinical and Research Institute</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2013</year></pub-date><pub-date pub-type="epub"><day>20</day><month>09</month><year>2024</year></pub-date><volume>15</volume><issue>2</issue><fpage>152</fpage><lpage>158</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Ветчинникова О.Н., Кулибаба С.А., Денисова Л.Б., Зулькарнаев А.Б., Патюков К.А., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Ветчинникова О.Н., Кулибаба С.А., Денисова Л.Б., Зулькарнаев А.Б., Патюков К.А.</copyright-holder><copyright-holder xml:lang="en">Vetchinnikova O.N., Kulibaba S.A., Denisova L.B., Zulkarnaev A.B., Patyukov K.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.nephro.ru/jour/article/view/593">https://journal.nephro.ru/jour/article/view/593</self-uri><abstract><p>Представлено клиническое наблюдение синдрома Сагликера при тяжелом течении вторичного гиперпаратиреоза у пациента с врожденной аномалией мочевыводящих путей, приведшей к терминальной почечной недостаточности и проведению заместительной терапии гемодиализом на протяжении 6 лет.</p></abstract><trans-abstract xml:lang="en"><p>A clinical case is described: a Sagliker syndrome patient with a severe secondary hyperparathyroidism and congenital anomalies of the urinary tracts which led to the end stage renal disease and subsequent hemodialysis therapy for 6 year follow-up.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>Sagliker syndrome</kwd><kwd>leontiasis osseous</kwd><kwd>secondary hyperparathyroidism</kwd><kwd>chronic kidney disease</kwd><kwd>Синдром Сагликера</kwd><kwd>костный леонтиаз</kwd><kwd>гиперпаратиреоз</kwd><kwd>хроническая болезнь почек</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Лейсле А.К., Мошнегуц С.В., Ушаков А.В. Костный леонтиаз: клиническое наблюдение и обзор литературы // Медицинская визуализация. 2011. № 2. C. 65 – 67.</mixed-citation><mixed-citation xml:lang="en">Лейсле А.К., Мошнегуц С.В., Ушаков А.В. Костный леонтиаз: клиническое наблюдение и обзор литературы // Медицинская визуализация. 2011. № 2. C. 65 – 67.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Armold A., Brown M. F., Urena P. et al. Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia // J Clin Invest. 1995. Vol. 95. P. 2047 – 2053.</mixed-citation><mixed-citation xml:lang="en">Armold A., Brown M. F., Urena P. et al. Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia // J Clin Invest. 1995. Vol. 95. P. 2047 – 2053.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Chang J.I., Som P.M., Lawson W. Unique imaging findings in the facial bones of renal osteodystrophy // Am J Neuroradiol. 2007. Vol. 28. P. 608 – 609.</mixed-citation><mixed-citation xml:lang="en">Chang J.I., Som P.M., Lawson W. Unique imaging findings in the facial bones of renal osteodystrophy // Am J Neuroradiol. 2007. Vol. 28. P. 608 – 609.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Dantas M., Costa R.S., Jorgetti V., et al. Facial leontiasis ossea: a rare presentation of hyperparathyroidism secondary to chronic renal insufficiency // Nephron. 1991. Vol. 58. P. 475–478.</mixed-citation><mixed-citation xml:lang="en">Dantas M., Costa R.S., Jorgetti V., et al. Facial leontiasis ossea: a rare presentation of hyperparathyroidism secondary to chronic renal insufficiency // Nephron. 1991. Vol. 58. P. 475–478.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Erkan A.N., Sagliker Y., Yildiz I., Ozluoglu L. Audiological findings in chronic kidney disease patients with Sagliker syndrome // J Ren Nutr. 2010. Vol. 20 (suppl 5). S56 – S58.</mixed-citation><mixed-citation xml:lang="en">Erkan A.N., Sagliker Y., Yildiz I., Ozluoglu L. Audiological findings in chronic kidney disease patients with Sagliker syndrome // J Ren Nutr. 2010. Vol. 20 (suppl 5). S56 – S58.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Ferrario V.F., Sforza C., Dellavia C. Facial changes in adult uremic patients on chronic dialysis: possible role of hyperparathyroidism // Int J Artif Organs. 2005. Vol. 28. P. 797 – 802.</mixed-citation><mixed-citation xml:lang="en">Ferrario V.F., Sforza C., Dellavia C. Facial changes in adult uremic patients on chronic dialysis: possible role of hyperparathyroidism // Int J Artif Organs. 2005. Vol. 28. P. 797 – 802.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Fukagawa M. Cell biology of parathyroid hyperplasia in uremia // Am J Med. Sci. 1999. Vol. 317. P. 377 – 382.</mixed-citation><mixed-citation xml:lang="en">Fukagawa M. Cell biology of parathyroid hyperplasia in uremia // Am J Med. Sci. 1999. Vol. 317. P. 377 – 382.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Giray S., Sagliker Y., Yildiz I., et al. Neurologic manifestations in Sagliker syndrome: uglifying human face appearance in severe and late secondary hyperparathyroidism in chronic renal failure patients // J Ren Nutr. 2006. Vol. 16. P. 233 – 236.</mixed-citation><mixed-citation xml:lang="en">Giray S., Sagliker Y., Yildiz I., et al. Neurologic manifestations in Sagliker syndrome: uglifying human face appearance in severe and late secondary hyperparathyroidism in chronic renal failure patients // J Ren Nutr. 2006. Vol. 16. P. 233 – 236.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Grzegorzewska A.E., Kaczmarek-Leki V. A case of severe long-term secondary hyperparathyroidism (Sagliker syndrome) in a patient treated with intermittent hemodialysis // Nefrologia i Dializoterapia Polska. 2011. Vol. 15. P. 57 – 60.</mixed-citation><mixed-citation xml:lang="en">Grzegorzewska A.E., Kaczmarek-Leki V. A case of severe long-term secondary hyperparathyroidism (Sagliker syndrome) in a patient treated with intermittent hemodialysis // Nefrologia i Dializoterapia Polska. 2011. Vol. 15. P. 57 – 60.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Ozenli Y., Giray S., Saglıker Y., Adam S.M. A controlled study of psychiatric manifestations and electroencephalography findings in chronic kidney disease patients with Sagliker syndrome // J Ren Nutr. 2010. Vol. 20 (suppl 5). S51 – S55.</mixed-citation><mixed-citation xml:lang="en">Ozenli Y., Giray S., Saglıker Y., Adam S.M. A controlled study of psychiatric manifestations and electroencephalography findings in chronic kidney disease patients with Sagliker syndrome // J Ren Nutr. 2010. Vol. 20 (suppl 5). S51 – S55.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Sagliker Y., Acharya V., Golea O. et al. Is survival enough for quality of life in Sagliker Syndrome—uglifying human face appearances in chronic kidney disease? // J Nephrol. 2008. Vol. 21 (suppl 13). S 134 – S 138.</mixed-citation><mixed-citation xml:lang="en">Sagliker Y., Acharya V., Golea O. et al. Is survival enough for quality of life in Sagliker Syndrome—uglifying human face appearances in chronic kidney disease? // J Nephrol. 2008. Vol. 21 (suppl 13). S 134 – S 138.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Sagliker Y., Acharya V., Ling Z. et al. International study on Sagliker syndrome and uglifying the human face of visibility in the heavy and late secondary hyperparathyroidism in chronic kidney disease patients // J Renal Nutr. 2008. Vol. 18. P. 114 – 117.</mixed-citation><mixed-citation xml:lang="en">Sagliker Y., Acharya V., Ling Z. et al. International study on Sagliker syndrome and uglifying the human face of visibility in the heavy and late secondary hyperparathyroidism in chronic kidney disease patients // J Renal Nutr. 2008. Vol. 18. P. 114 – 117.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Sagliker Y, Balal М, Sagliker Ozkaynak P. et al. Sagliker syndrome: uglifying human face, look in the end and severe secondary hyperparathyroidism in chronic renal failure // Semin Nephrol. 2004. Vol. 24 (5). P. 449 – 455.</mixed-citation><mixed-citation xml:lang="en">Sagliker Y, Balal М, Sagliker Ozkaynak P. et al. Sagliker syndrome: uglifying human face, look in the end and severe secondary hyperparathyroidism in chronic renal failure // Semin Nephrol. 2004. Vol. 24 (5). P. 449 – 455.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Salem M. hyperparathyroidism in the hemodialysis population: a survey of 612 patients // Am J Kidney Dis. 1997. Vol. 29. P. 862 – 685.</mixed-citation><mixed-citation xml:lang="en">Salem M. hyperparathyroidism in the hemodialysis population: a survey of 612 patients // Am J Kidney Dis. 1997. Vol. 29. P. 862 – 685.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Slatopolsky E., Brown A., Dusso A. Pathogenesis of secondary hyperparathyroidism // Kidney Int. 2005. Vol. 56 (Suppl. 73). S 14 –S 19.</mixed-citation><mixed-citation xml:lang="en">Slatopolsky E., Brown A., Dusso A. Pathogenesis of secondary hyperparathyroidism // Kidney Int. 2005. Vol. 56 (Suppl. 73). S 14 –S 19.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Uzel A., Uzel I., Sagliker Y., et al. Cephalometric evaluation of patients with Sagliker Syndrome: uglifying human face appearance in severe and late secondary hyperparathyroidism in chronic renal failure patients // J Renal Nutr. 2006. Vol. 16. P. 229 – 232.</mixed-citation><mixed-citation xml:lang="en">Uzel A., Uzel I., Sagliker Y., et al. Cephalometric evaluation of patients with Sagliker Syndrome: uglifying human face appearance in severe and late secondary hyperparathyroidism in chronic renal failure patients // J Renal Nutr. 2006. Vol. 16. P. 229 – 232.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Yildiz I., Sagliker Y., Demirhan O. et al. International evaluation of unrecognizably uglifying human faces in late and severe secondary hyperparathyroidism in chronic kidney disease. Sagliker syndrome. A unique catastrophic entity, cytogenetic studies for chromosomal abnormalities, calcium-sensing receptor gene and GNAS1 mutations. Striking and promising missense mutations on the GNAS1 gene exons 1, 4, 10, 4 // J Ren Nutr. 2012. Vol. 22 (1). P. 157 – 161.</mixed-citation><mixed-citation xml:lang="en">Yildiz I., Sagliker Y., Demirhan O. et al. International evaluation of unrecognizably uglifying human faces in late and severe secondary hyperparathyroidism in chronic kidney disease. Sagliker syndrome. A unique catastrophic entity, cytogenetic studies for chromosomal abnormalities, calcium-sensing receptor gene and GNAS1 mutations. Striking and promising missense mutations on the GNAS1 gene exons 1, 4, 10, 4 // J Ren Nutr. 2012. Vol. 22 (1). P. 157 – 161.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
